tiprankstipranks
Trending News
More News >
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
Hong Kong Market

Clover Biopharmaceuticals Ltd. (2197) Price & Analysis

Compare
0 Followers

2197 Stock Chart & Stats


Financials

2197 FAQ

What was Clover Biopharmaceuticals Ltd.’s price range in the past 12 months?
Clover Biopharmaceuticals Ltd. lowest stock price was HK$0.18 and its highest was HK$0.58 in the past 12 months.
    What is Clover Biopharmaceuticals Ltd.’s market cap?
    Clover Biopharmaceuticals Ltd.’s market cap is HK$395.60M.
      When is Clover Biopharmaceuticals Ltd.’s upcoming earnings report date?
      Clover Biopharmaceuticals Ltd.’s upcoming earnings report date is Aug 20, 2025 which is in 45 days.
        How were Clover Biopharmaceuticals Ltd.’s earnings last quarter?
        Clover Biopharmaceuticals Ltd. released its earnings results on Mar 31, 2025. The company reported -HK$0.717 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.717.
          Is Clover Biopharmaceuticals Ltd. overvalued?
          According to Wall Street analysts Clover Biopharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Clover Biopharmaceuticals Ltd. pay dividends?
            Clover Biopharmaceuticals Ltd. does not currently pay dividends.
            What is Clover Biopharmaceuticals Ltd.’s EPS estimate?
            Clover Biopharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Clover Biopharmaceuticals Ltd. have?
            Clover Biopharmaceuticals Ltd. has 1,297,062,400 shares outstanding.
              What happened to Clover Biopharmaceuticals Ltd.’s price movement after its last earnings report?
              Clover Biopharmaceuticals Ltd. reported an EPS of -HK$0.717 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12%.
                Which hedge fund is a major shareholder of Clover Biopharmaceuticals Ltd.?
                Currently, no hedge funds are holding shares in HK:2197

                Clover Biopharmaceuticals Ltd. Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -7.57%
                12-Months-Change

                Fundamentals

                Return on Equity
                Trailing 12-Months
                Asset Growth
                -62.62%
                Trailing 12-Months

                Company Description

                Clover Biopharmaceuticals Ltd.

                Clover Biopharmaceuticals Ltd. (2197) is a global clinical-stage biotechnology company focused on discovering, developing, and commercializing transformative biologic therapies. The company primarily operates in the biopharmaceutical sector, with a core emphasis on developing vaccines and biologic therapies for infectious diseases and cancer. Clover Biopharmaceuticals leverages its proprietary Trimer-Tag technology platform to create innovative treatments aimed at addressing significant unmet medical needs worldwide.
                Similar Stocks
                Company
                Price & Change
                Follow
                Transcenta Holding Limited
                Sirnaomics Ltd.
                Jiangsu Recbio Technology Co., Ltd. Class H
                HBM Holdings Ltd.
                Kintor Pharmaceutical Ltd
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis